LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC (www.Goldberglawpc.com) reminds investors in Avalanche Biotechnologies, Inc. (“Avalanche” or the “Company”) (NASDAQ: AAVL), who purchased or otherwise acquired shares between July 31, 2014 and June 15, 2015, inclusive (the “Class Period”), of the September 8, 2015 deadline to file a motion to be appointed as lead plaintiff. If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall
| < Prev | Next > |
|---|
